News

Select a news topic from the list below, then select a news article to read.

TLR4 as an important target in SARS-COV2 therapy

  Rationale COVID-19 may present with mild, moderate, or severe illness. The severe clinical manifestations include severe pneumonia, Acute Respiratory Syndrome (ARDS), sepsis, and septic shock (Cascella M, Rajnik M, Cuomo A, et al. Features, Evaluation and Treatment Coronavirus (COVID-19) [Updated 2020 Mar 8]. In: StatPearls-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK554776/). While the virus itself is only moderately pathogenic and about 50% of infected individuals barely notice (“a bad flu”). The others suffer from

Malattie neurodegenerative, scoperto un meccanismo che “fa bene” alle staminali

    Milano, 1 marzo 2018 – Scoperto il “lato buono” del recettore TLR4. Normalmente responsabile dei fenomeni infiammatori, il TLR4, se opportunamente stimolato può favorire la crescita e la differenziazione delle cellule staminali neurali (NSC), attualmente in sperimentazione per una serie di malattie del sistema nervoso, come la sclerosi laterale amiotrofica (SLA) e la sclerosi multipla (SM). Lo rivela lo studio “Toll-like receptor 4 modulation influences human neural stem cell proliferation